SLC2A13P1

Across TCGA pan-cancer cohorts, SLC2A13P1 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated SLC2A13P1 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher SLC2A13P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SLC2A13P1 expression acts as an unfavorable survival marker.

UVM, CESC, and KIRC are the cancer types where SLC2A13P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.250	0.865	<.001	126	view →
CESC	OS	Tertile	II,III,IV	0.047	0.830	<.001	72	view →
KIRC	DFS	Tertile	II,III,IV	0.221	0.760	.017	54	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
UCEC	DFS	Tertile	All	0.151	0.654	<.001	36	view →
SARC	OS	Tertile	All	0.246	0.752	<.001	36	view →
SKCM	DFS	Tertile	IV	0.040	0.454	.028	24	view →
ESCA	DFS	Tertile	III,IV	0.166	0.459	.003	18	view →
COAD	OS	Tertile	II,III,IV	0.264	0.791	.018	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

SLC2A13P1–UVM (OS)

Open the UVM breakdown →